Rosetta Genomics Ltd. (USA) operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Rosetta Genomics Ltd. (USA) with three other pharmaceutical manufacturers in Middle East: October Pharma For Pharmaceutical Industries SAE of EGYPT (2016 sales of 288.11 million Egyptian Pounds [US$18.42 million] ), Hayat Pharmaceutical Industries Company PSC of JORDAN (10.54 million Jordanian Dinars [US$14.86 million] ), and Philadelphia Pharmaceuticals Industry Company PSC which is also based in JORDAN (6.80 million Jordanian Dinars [US$9.59 million] ).

Sales Analysis. Rosetta Genomics Ltd. (USA) reported sales of 35.31 million Israel Shekels (US$10.80 million) for the year ending December of 2016. This represents an increase of 9.9% versus 2015, when the company's sales were 32.13 million Israel Shekels. Sales at Rosetta Genomics Ltd. (USA) have increased during each of the previous five years (and since 2011, sales have increased a total of 9,497%).